Researchers at the University of California, San Diego School of Medicine have identified a gene variant that may be used to predict people most likely to respond to an investigational therapy under development for Alzheimer's disease (AD).
from The Medical News http://ift.tt/1FhBAY9
from The Medical News http://ift.tt/1FhBAY9
No comments:
Post a Comment